| Dr Taketo Baba, MD | |
|
6621 Fannin St, Houston, TX 77030-2358 | |
| (832) 824-1000 | |
| Not Available |
| Full Name | Dr Taketo Baba |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Emergency Medicine |
| Location | 6621 Fannin St, Houston, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003047952 | NPI | - | NPPES |
| Entity Name | University Of Texas Southwestern Medical Center At Dallas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972579365 PECOS PAC ID: 0648188250 Enrollment ID: O20031106000792 |
News Archive
In a study published online in the Journal of Allergy and Clinical Immunology, researchers at Washington University School of Medicine in St. Louis and five other sites nationwide found that children who showed the most improvement in days without wheezing using an inhaled corticosteroid drug were caucasian boys who had allergies and had a hospitalization or emergency department visit for asthma symptoms in the year prior to the trial.
Xcovery, a developer of targeted therapeutics for ALK+ non-small cell lung cancer (NSCLC) is scheduled to present January 6th, 2016 at the fourth annual AACR-IASLC International Joint Conference: Lung Cancer Translational Science from the Bench to the Clinic, at the Hard Rock Hotel, in San Diego, CA.
Recent work led by Carnegie's Kamena Kostova revealed a new quality control system in the protein production assembly line with possible implications for understanding neurogenerative disease.
Seroprevalence studies have proved their worth in estimating the size and directionality of an outbreak of infectious disease, especially the current pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced coronavirus disease 2019 (COVID-19). A new study posted to the medRxiv* preprint server describes the prevalence of SARS-CoV-2 antibodies in five representative regions of Germany.
Penn Medicine will establish the Philadelphia region's first dedicated center for the treatment and research of blood diseases by combining the expertise of physicians who specialize in the care of blood disorder patients of all ages along with basic science and clinical researchers who are working to advance treatments for these illnesses.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Taketo Baba, MD 6621 Fannin St Ste A2210, Houston, TX 77030-2374 Ph: () - | Dr Taketo Baba, MD 6621 Fannin St, Houston, TX 77030-2358 Ph: (832) 824-1000 |
News Archive
In a study published online in the Journal of Allergy and Clinical Immunology, researchers at Washington University School of Medicine in St. Louis and five other sites nationwide found that children who showed the most improvement in days without wheezing using an inhaled corticosteroid drug were caucasian boys who had allergies and had a hospitalization or emergency department visit for asthma symptoms in the year prior to the trial.
Xcovery, a developer of targeted therapeutics for ALK+ non-small cell lung cancer (NSCLC) is scheduled to present January 6th, 2016 at the fourth annual AACR-IASLC International Joint Conference: Lung Cancer Translational Science from the Bench to the Clinic, at the Hard Rock Hotel, in San Diego, CA.
Recent work led by Carnegie's Kamena Kostova revealed a new quality control system in the protein production assembly line with possible implications for understanding neurogenerative disease.
Seroprevalence studies have proved their worth in estimating the size and directionality of an outbreak of infectious disease, especially the current pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced coronavirus disease 2019 (COVID-19). A new study posted to the medRxiv* preprint server describes the prevalence of SARS-CoV-2 antibodies in five representative regions of Germany.
Penn Medicine will establish the Philadelphia region's first dedicated center for the treatment and research of blood diseases by combining the expertise of physicians who specialize in the care of blood disorder patients of all ages along with basic science and clinical researchers who are working to advance treatments for these illnesses.
› Verified 7 days ago
Sonia Ann Monteiro, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6701 Fannin St, Houston, TX 77030 Phone: 832-824-1000 | |
Meenakshi G Hegde, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6701 Fannin St, Houston, TX 77030 Phone: 832-824-1000 | |
Rebecca Jean Chancey, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 6621a Fannin St., Houston, TX 77030 Phone: 713-770-5454 | |
Lisa R Lapeze, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 18338 Kingsland Blvd, Suite 210, Houston, TX 77094 Phone: 281-599-7334 Fax: 281-599-7040 | |
Elvis Aaron Cavazos, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 14730 Barryknoll Ln, Houston, TX 77079 Phone: 281-496-9700 Fax: 281-496-7821 | |
Marlene D. Typaldos Sanchez, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6701 Fannin St Ste 1040, Houston, TX 77030 Phone: 832-822-3309 Fax: 832-825-3308 | |
Steven Cook, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3023 Kirby Drive, Suite 200, Houston, TX 77098 Phone: 713-526-6443 |